Bacac, Marina,Colombetti, Sara,Klein, Christian,Sam, Johannes,Saro, Jose,Umaña, Pablo
申请号：
AU2017205089
公开号：
AU2017205089A1
申请日:
2017.01.05
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention provides compositions and methods for treating CEA-positive cancers. The method comprising administering a PD-1 axis binding antagonist and a bispecific antibody that targets CEA and CD3.
